Indications for ICD and CRT-D
ICD is indicated for patients with LVEF ≤35% who are >40 days post-MI or >3 months on guideline-directed medical therapy (GDMT) with NYHA class II-III symptoms, and CRT-D is indicated when these patients also have LBBB with QRS ≥150 ms and sinus rhythm. 1
ICD Indications
Primary Prevention (Class 1 Recommendations)
For patients at risk of sudden cardiac death, ICD implantation requires:
- LVEF ≤35% on GDMT for ≥3 months 1
- >40 days post-myocardial infarction if ischemic cardiomyopathy 1
- NYHA class II or III symptoms (ambulatory patients) 1
The evidence supporting ICD for primary prevention demonstrates reduced all-cause mortality in patients with previous ventricular arrhythmias, remote MI (>3 weeks), or non-ischemic cardiomyopathy with LVEF ≤35%. 2 Cost-effectiveness analyses show ICERs consistently <£30,000 per QALY when life expectancy increases by >1.4 years. 1, 2
Secondary Prevention
ICD is indicated for survivors of cardiac arrest due to ventricular fibrillation or hemodynamically unstable ventricular tachycardia, unless reversible causes are identified. 3, 4
Special Populations
- Genetic arrhythmogenic cardiomyopathy with high-risk features and EF ≤45%: ICD is reasonable (Class 2a) 1
- Recent MI (<40 days): ICD shows reduction in sudden cardiac death but NOT all-cause mortality, therefore not routinely indicated 2
- Scheduled for CABG: ICD provides no benefit 2
CRT-D Indications
Strongest Indications (Class 1)
CRT-D is indicated when ALL of the following criteria are met: 1
- LVEF ≤35% on GDMT
- Sinus rhythm
- LBBB pattern with QRS ≥150 ms
- NYHA class II, III, or ambulatory IV symptoms
This combination reduces total mortality, hospitalizations, and improves symptoms and quality of life. 1
Moderate Strength Indications (Class 2a)
CRT can be useful in these scenarios: 1
LBBB with QRS 120-149 ms (narrower QRS): Still beneficial for NYHA II-IV patients with LVEF ≤35% 1
Atrial fibrillation patients with LVEF ≤35%: CRT is useful IF:
- Patient requires ventricular pacing or meets CRT criteria AND
- AV nodal ablation or rate control achieves near 100% ventricular pacing 1
Anticipated significant ventricular pacing (>40%): For new or replacement device implantation in patients with LVEF ≤35% 1
Weaker Indications (Class 2b)
CRT may be considered in: 1
- Non-LBBB pattern with QRS 120-149 ms and NYHA class III-IV symptoms
- NYHA class I symptoms with ischemic cardiomyopathy, LVEF ≤30%, LBBB, and QRS ≥150 ms
CRT-D vs CRT-P Decision
CRT-D is preferred over CRT-P when ICD criteria are also met (LVEF ≤35%, appropriate functional class). 2 The rate of sudden cardiac death is lower with CRT-D than CRT-P, though other outcomes are similar. 2 The incremental cost-effectiveness ratio for CRT-D compared to CRT-P is £28,420 per QALY. 2
For patients with both heart failure and ICD indications, CRT-D reduces all-cause mortality and HF hospitalizations compared to ICD alone, with an ICER of £27,195 per QALY. 2
Contraindications (Class 3: No Benefit)
Do NOT implant ICD or CRT-D in: 1
- QRS duration <120 ms: CRT provides no benefit 1
- NYHA class I-II with non-LBBB pattern and QRS <150 ms: CRT not recommended 1
- Life expectancy <1 year due to comorbidities or frailty with poor functional capacity 1
Critical Timing Considerations
GDMT must be optimized BEFORE device implantation to assess whether LVEF improves, as this may eliminate the indication for device therapy. 1 The 3-month GDMT requirement for non-ischemic cardiomyopathy and 40-day post-MI requirement for ischemic cardiomyopathy are mandatory waiting periods. 1
Common Pitfalls
- Implanting devices too early: Always wait the required time on GDMT or post-MI to allow for potential LVEF recovery 1
- Ignoring QRS morphology: Non-LBBB patterns have weaker evidence, particularly with QRS <150 ms 1
- Inadequate ventricular pacing in AF patients: CRT requires near 100% ventricular capture; consider AV nodal ablation if rate control insufficient 1
- Complications with CRT-D: More common than with ICD alone, requiring careful patient selection 2